PIONEER 1 compared oral semaglutide with placebo [76], while PIONEER 24 compared oral semaglutide with the SGLT2i empagliflozin (25 mg once daily), the DPP-4 inhibitor sitagliptin (100 mg once daily), and the subcutaneous GLP-1RA liraglutide (1.8 mg once daily) [38, 39, 61, 62]
Many patients experience: Reduced appetite Fewer food cravings Improved portion control Steady, sustainable weight loss What Is Tirzepatide
However, there are major differences between these medications, including how they affect your body and how long you should use them
Beyond weight loss, semaglutide can improve metabolic markers such as blood sugar levels, cholesterol, and inflammation, reducing the risk of chronic diseases